Nonsteroidal anti-inflammatory drugs, COX-2 and colorectal cancer

Toxicology Letters

Volumn 112-113, Issue , 2000, Pages 493-498

  Patrignani, Paola ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Colorectal cancer; Cyclooxygenase 2; Nonsteroidal anti inflammatory drugs; Specific COX 2 inhibitors

Indexed keywords

6 (2,4 DIFLUOROPHENYLTHIO) 5 METHANESULFONAMIDO 1 INDANONE; ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; MELOXICAM; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; SULINDAC;

ADENOMATOUS POLYP; ARACHIDONIC ACID METABOLISM; CANCER PREVENTION; COLORECTAL CANCER; CONFERENCE PAPER; ENZYME ACTIVITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR;

ADENOMATOUS POLYPOSIS COLI; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; COLORECTAL NEOPLASMS; CYCLOOXYGENASE INHIBITORS; HUMANS; SULINDAC;

EID: 17344389992     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(99)00210-6     Document Type: Conference Paper

References (30)

1. Catella-Lawson F., McAdam B., Morrison B.W., Kapoor S., Kujubu D., Antes L., Lasseter K.C., Quan H., Getz B.J., FitzGerald G.A. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J. Pharmacol. Exp. Ther. 289:1999;735-741.
2. Cipollone F., Patrignani P., Greco A., Panara M.R., Padovano R., Cuccurullo F., Patrono C., Rebuzzi A.G., Liuzzo G., Quaranta G., Maseri A. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. Circulation. 96:1997;1109-1116.
3. Dubois R.N., Abramson S.B., Crofford L., Gupta R.A., Simon L.S., Van de Putte L.B.A., Lipsky P.E. Cyclooxygenase in biology and disease. FASEB J. 12:1998;1063-1073.
4. Ehrich E., Dallob A., De Lepeleire I., Van Hecken A., Riendeau D., Yuang W., Parras A., Wittreich J., Seibold J.R., De Schepper P., Mehlisch D.R., Gertz B.J. Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model. Clin. Pharmacol. Ther. 65:1999;336-347.
5. Giardiello F.M., Stanley R.H., Krush A.J., Piantadosi S., Hylind L.M., Celano P., Booker S.D., Robinson C.R., Offerhaus G.J.A. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med. 328:1993;1313-1316.
6. Giovannucci E., Egan K.M., Hunter D.J., Stampfer M.J., Colditz G.A., Willett W.C., Speizer F.E. Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med. 333:1995;609-614.
7. Lecomte M., Laneuville O., Ji C., DeWitt D.L., Smith W.L. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. J. Biol. Chem. 269:1994;13207-13215.
8. Levy G.N. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer. FASEB J. 11:1997;234-247.
9. McAdam B.F., Catella-Lawson F., Mardini I.A., Kapoor S., Lawson J.A., FitzGerald G.A. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc. Natl. Acad. Sci. USA. 96:1999;272-277.
10. Δ716 knockout mice by inhibition of cyclooxygenase 2 (PGHS-2). Cell. 87:1996;803-809.
11. Panara M.R., Padovano R., Sciulli M.G., Santini G., Renda G., Rotondo M.T., Pace A., Patrono C., Patrignani P. Effects of nimesulide on constitutive and inducible prostanoid biosynthesis in man. Clin. Pharmacol. Ther. 63:1998;672-681.
12. Panara, M.R., Renda, G., Sciulli, M.G., Santini, G., Di Giamberardino, M., Rotondo, M.T., Tacconelli, S., Seta, F., Patrono, C., Patrignani, P., 1999. Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects. J. Pharmacol. Exp. Ther. (in press).
13. Patrignani P., Filabozzi P., Patrono C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J. Clin. Invest. 69:1982;1366-1372.
14. Patrignani P., Panara M.R., Greco A., Fusco O., Natoli C., Iacobelli S., Cipollone F., Ganci A., Creminon C., Maclouf J., Patrono C. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J. Pharmacol. Exp. Ther. 271:1994;1705-1712.
15. 2 production in healthy subjects. Thromb. Res. 17:1980;317-327.
16. Qiao L., Kozoni V., Tsioulias G.J., Koutsos M.I., Hanif R., Shiff S.J., Rigas B. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochim. Biophys. Acta. 1258:1995;215-223.
17. Reddy B.S., Rao C.V., Seibert K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res. 56:1996;4566-4569.
18. Rigas B., Goldman I.S., Levine L. Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med. 122:1993;518-523.
19. Roth G.J., Majerus P.W. The mechanism of the effect of aspirin on human platelets: acetylation of a particulate protein fraction. J. Clin. Invest. 56:1975;624-632.
20. Sano H., Kawahito Y., Wilder R.L., Hashiramoto A., Mukai S., Asai K., Kimura S., Kato H., Kondo M., Hla T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55:1995;3785-3789.
21. WAF-1/cip1, apoptosis and differentiation by L-745,337, a selective PGH synthase-2 inhibitor, and salicylate in HT-29 cells. Apoptosis. 4:1999;151-162.
22. Sheng H., Shao J., Kirkland S.C., Isakson P., Coffey R.J., Morrow J., Beauchamp R.D., Dubois R.N. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest. 99:1997;2254-2259.
23. Shiff S.J., Koutsos M.I., Qiao L., Rigas B. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis. Exp. Cell Res. 222:1996;179-188.
24. Simon L.S., Lanza F.L., Lipsky P.E., Hubbard R.C., Talwalker S., Schwartz B.D., Isakson P.C., Geis G.S. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase-2 inhibitor. Arthritis Rheum. 41:1998;1591-1602.
25. Smith W.L., Garavito R.M., DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem. 271:1996;33157-33160.
26. Thun M.J. Aspirin, NSAIDs, and digestive tract cancers. Cancer Metast. Rev. 13:1994;269-277.
27. Vane J.R. Inhibition of prostaglandins as a mechanism of action for aspirin-like drugs. Nature New Biol. 231:1971;232-235.
28. Vane J.R. Towards a better aspirin. Nature. 367:1994;215-216.
29. Vio C.P., Cespedes C., Gallardo P., Masferrer J.L. Renal identification of cyclooxygenase-2 in a subset of thick ascending limb cells. Hypertension. 30:1997;687-692.
30. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron. 11:1993;371-386.